New CML drug asciminib under Real-World study

NCT ID NCT07549516

First seen Jun 27, 2026 · Last updated Aug 13, 2026 · Updated 6 times

Summary

This study is watching how well asciminib works and how safe it is in adults with a type of blood cancer called chronic myeloid leukemia. It includes people who are newly diagnosed or have already tried one other treatment. The main goal is to see how many patients reach a very low level of cancer cells after 12 months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LEUKEMIA, CHRONIC MYELOID are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic myelogenous leukemia, BCR-ABL1 positive Leukemia, Myelogenous, Chronic, BCR-ABL Positive

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Novartis Investigative Site

    RECRUITING

    Baden-Baden, Baden-Wurttemberg, 76532, Germany

  • Novartis Investigative Site

    RECRUITING

    Heidenheim, Baden-Wurttemberg, 89522, Germany

  • Novartis Investigative Site

    RECRUITING

    Schwäbisch Hall, Baden-Wurttemberg, 74523, Germany

  • Novartis Investigative Site

    RECRUITING

    Winnenden, Baden-Wurttemberg, 71364, Germany

  • Novartis Investigative Site

    RECRUITING

    Aschaffenburg, Bavaria, 63739, Germany

  • Novartis Investigative Site

    RECRUITING

    Augsburg, Bavaria, 86152, Germany

  • Novartis Investigative Site

    RECRUITING

    Donauwörth, Bavaria, 86609, Germany

  • Novartis Investigative Site

    RECRUITING

    Herrsching am Ammersee, Bavaria, 82211, Germany

  • Novartis Investigative Site

    RECRUITING

    Kempten (Allgäu), Bavaria, 87439, Germany

  • Novartis Investigative Site

    RECRUITING

    Landsberg am Lech, Bavaria, 86899, Germany

  • Novartis Investigative Site

    RECRUITING

    Munich, Bavaria, 81241, Germany

  • Novartis Investigative Site

    RECRUITING

    Regensburg, Bavaria, 93053, Germany

  • Novartis Investigative Site

    RECRUITING

    Bremerhaven, Free Hanseatic City of Bremen, 27576, Germany

  • Novartis Investigative Site

    RECRUITING

    Kassel, Hesse, 34125, Germany

  • Novartis Investigative Site

    RECRUITING

    Offenbach, Hesse, 63065, Germany

  • Novartis Investigative Site

    RECRUITING

    Rotenburg (Wümme), Lower Saxony, 27356, Germany

  • Novartis Investigative Site

    RECRUITING

    Twistringen, Lower Saxony, 27239, Germany

  • Novartis Investigative Site

    RECRUITING

    Cologne, North Rhine-Westphalia, 50674, Germany

  • Novartis Investigative Site

    RECRUITING

    Cologne, North Rhine-Westphalia, 50677, Germany

  • Novartis Investigative Site

    RECRUITING

    Solingen, North Rhine-Westphalia, 42653, Germany

  • Novartis Investigative Site

    RECRUITING

    Wesel, North Rhine-Westphalia, 46483, Germany

  • Novartis Investigative Site

    RECRUITING

    Zittau, Saxony, 02763, Germany

  • Novartis Investigative Site

    RECRUITING

    Merseburg, Saxony-Anhalt, 06217, Germany

  • Novartis Investigative Site

    RECRUITING

    Oldenburg in Holstein, Schleswig-Holstein, 23758, Germany

  • Novartis Investigative Site

    RECRUITING

    Saalfeld, Thuringia, 07318, Germany

  • Novartis Investigative Site

    RECRUITING

    Bad Friedrichshall, 74177, Germany

  • Novartis Investigative Site

    RECRUITING

    Bad Liebenwerda, 04924, Germany

  • Novartis Investigative Site

    RECRUITING

    Berlin, 10559, Germany

  • Novartis Investigative Site

    RECRUITING

    Berlin, 12487, Germany

  • Novartis Investigative Site

    RECRUITING

    Bremerhaven, 27568, Germany

  • Novartis Investigative Site

    RECRUITING

    Buchholz Nordheide, 21244, Germany

  • Novartis Investigative Site

    RECRUITING

    Cottbus, 03046, Germany

  • Novartis Investigative Site

    RECRUITING

    Detmold, 32756, Germany

  • Novartis Investigative Site

    RECRUITING

    Dorfen, 84405, Germany

  • Novartis Investigative Site

    RECRUITING

    Dortmund, 44263, Germany

  • Novartis Investigative Site

    RECRUITING

    Dresden, 01307, Germany

  • Novartis Investigative Site

    RECRUITING

    Düren, 52353, Germany

  • Novartis Investigative Site

    RECRUITING

    Erfurt, 99085, Germany

  • Novartis Investigative Site

    RECRUITING

    Göttingen, 37073, Germany

  • Novartis Investigative Site

    RECRUITING

    Hanover, 30161, Germany

  • Novartis Investigative Site

    RECRUITING

    Hanover, 30625, Germany

  • Novartis Investigative Site

    RECRUITING

    Hildesheim, 31135, Germany

  • Novartis Investigative Site

    RECRUITING

    Kiel, 24105, Germany

  • Novartis Investigative Site

    RECRUITING

    Leipzig, 04103, Germany

  • Novartis Investigative Site

    RECRUITING

    Leverkusen, 51375, Germany

  • Novartis Investigative Site

    RECRUITING

    Mutlangen, 73557, Germany

  • Novartis Investigative Site

    RECRUITING

    Naunhof, 04683, Germany

  • Novartis Investigative Site

    RECRUITING

    Neuss, 41462, Germany

  • Novartis Investigative Site

    RECRUITING

    Offenburg, 77654, Germany

  • Novartis Investigative Site

    RECRUITING

    Oldenburg, 26121, Germany

  • Novartis Investigative Site

    RECRUITING

    Parchim, 19370, Germany

  • Novartis Investigative Site

    RECRUITING

    Potsdam, 14467, Germany

  • Novartis Investigative Site

    RECRUITING

    Potsdam, 14482, Germany

  • Novartis Investigative Site

    RECRUITING

    Schorndorf, 73614, Germany

  • Novartis Investigative Site

    RECRUITING

    Soest, 59494, Germany

  • Novartis Investigative Site

    RECRUITING

    Stade, 21680, Germany

  • Novartis Investigative Site

    RECRUITING

    Wetzlar, 35578, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.